Group 1 - The company Huajian Medical (01931) announced a proposed acquisition of approximately 1.848 billion shares of Guofu Quantum (00290), representing 20.31% of the target company's total issued share capital, for about HKD 3.142 billion, to be paid through the issuance of shares at an issue price of HKD 9.69 per share [1] - The target group primarily engages in investment banking, securities brokerage, asset management, margin financing, lending, debt investment, equity investment, and immigration consulting, while actively investing in the quantum technology industry [1] - This acquisition is a significant step for the company in advancing its RWA exchange strategy and achieving ecological synergy, highlighting its deep industrial significance and capital value [1] Group 2 - Upon completion of the acquisition, Huajian Medical will collaborate with Guofu Quantum to build a comprehensive strategic synergy around "on-chain finance," promoting innovation and implementation of digital financial infrastructure [1] - The two companies will integrate technology, licenses, assets, and channel resources to create an efficient, compliant, and open platform for on-chain asset issuance, trading, and management, accelerating the digitalization, fragmentation, and cross-border flow of traditional financial assets [1]
华检医疗拟发行约31.42亿港元代价股份收购国富量子20.31%股权 进一步完善在RWA与数字金融领域的战略布局